These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 18952240
1. Comparison of the therapeutic efficacy of linezolid and vancomycin and correlation of serum and tissue malondialdehyde and myeloperoxidase in an experimental mediastinitis model. Sacar S, Sacar M, Aybek H, Turgut H, Onem G, Cevahir N, Teke Z, Kaleli I, Guler A, Ucak A, Baltalarli A. J Surg Res; 2009 Mar; 152(1):89-95. PubMed ID: 18952240 [Abstract] [Full Text] [Related]
2. Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis. Turhan V, Sacar S, Uzun G, Sacar M, Yildiz S, Ceran N, Gorur R, Oncul O. J Surg Res; 2009 Jul; 155(1):111-5. PubMed ID: 19181335 [Abstract] [Full Text] [Related]
3. Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: an experimental study. Sacar M, Sacar S, Kaleli I, Cevahir N, Teke Z, Kavas ST, Asan A, Aytekin FO, Baltalarli A, Turgut H. Int J Infect Dis; 2008 Jul; 12(4):396-401. PubMed ID: 18162429 [Abstract] [Full Text] [Related]
4. Ozone therapy as an adjunct to vancomycin enhances bacterial elimination in methicillin resistant Staphylococcus aureus mediastinitis. Gulmen S, Kurtoglu T, Meteoglu I, Kaya S, Okutan H. J Surg Res; 2013 Nov; 185(1):64-9. PubMed ID: 23809152 [Abstract] [Full Text] [Related]
5. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs. Martinez-Olondris P, Rigol M, Soy D, Guerrero L, Agusti C, Quera MA, Li Bassi G, Esperatti M, Luque N, Liapikou M, Filella X, Marco F, de la Bellacasa JP, Torres A. Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613 [Abstract] [Full Text] [Related]
6. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis. Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I, Pelekanou A, Giamarellos-Bourboulis EJ, Giamarellou H, Kanellakopoulou K. J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576 [Abstract] [Full Text] [Related]
7. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model. Conaughty JM, Chen J, Martinez OV, Chiappetta G, Brookfield KF, Eismont FJ. Spine (Phila Pa 1976); 2006 Oct 15; 31(22):E830-2. PubMed ID: 17047530 [Abstract] [Full Text] [Related]
8. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, Niki Y, Watanabe S, Furue M, Ito T, Croos-Dabrera R, Tack KJ. J Antimicrob Chemother; 2007 Dec 15; 60(6):1361-9. PubMed ID: 17913720 [Abstract] [Full Text] [Related]
9. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model. Yin LY, Calhoun JH, Thomas TS, Wirtz ED. J Antimicrob Chemother; 2009 Feb 15; 63(2):357-60. PubMed ID: 19060292 [Abstract] [Full Text] [Related]
10. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model. Barnea Y, Carmeli Y, Kuzmenko B, Navon-Venezia S. J Antimicrob Chemother; 2008 Dec 15; 62(6):1339-43. PubMed ID: 18799473 [Abstract] [Full Text] [Related]
11. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, Kim NJ, Kim EC, Oh MD, Choe KW. Clin Infect Dis; 2009 Aug 01; 49(3):395-401. PubMed ID: 19569970 [Abstract] [Full Text] [Related]
12. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. Giacometti A, Ghiselli R, Cirioni O, Mocchegiani F, Orlando F, Del Prete MS, D'Amato G, Silvestri C, Saba V, Scalise G. J Antimicrob Chemother; 2003 Oct 01; 52(4):724-6. PubMed ID: 12951347 [Abstract] [Full Text] [Related]
13. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. Shorr AF, Kunkel MJ, Kollef M. J Antimicrob Chemother; 2005 Nov 01; 56(5):923-9. PubMed ID: 16195255 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients. Kosaka T, Kokufu T, Shime N, Sugioka N, Kato R, Hamaoka K, Fujita N. Int J Antimicrob Agents; 2009 Apr 01; 33(4):368-70. PubMed ID: 19097868 [Abstract] [Full Text] [Related]
18. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ. Clin Infect Dis; 2006 Mar 01; 42(5):597-607. PubMed ID: 16447103 [Abstract] [Full Text] [Related]
19. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France. De Cock E, Sorensen S, Levrat F, Besnier JM, Dupon M, Guery B, Duttagupta S. Med Mal Infect; 2009 May 01; 39(5):330-40. PubMed ID: 19304423 [Abstract] [Full Text] [Related]